These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1907589)

  • 1. Anticardiolipin antibodies in patients with venous thrombosis.
    Kapiotis S; Speiser W; Pabinger-Fasching I; Kyrle PA; Lechner K
    Haemostasis; 1991; 21(1):19-24. PubMed ID: 1907589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis.
    Canoso RT; de Oliveira RM
    Am J Hematol; 1988 Apr; 27(4):272-5. PubMed ID: 3128108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.
    Sitter T; Spannagl M; Schiffl H
    Ann Hematol; 1992 Aug; 65(2):79-82. PubMed ID: 1511061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.
    Shi W; Krilis SA; Chong BH; Gordon S; Chesterman CN
    Aust N Z J Med; 1990 Jun; 20(3):231-6. PubMed ID: 2115326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.
    Pelkonen P; Simell O; Rasi V; Vaarala O
    Acta Paediatr Scand; 1988 Sep; 77(5):767-72. PubMed ID: 3144118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin syndrome in childhood: a report of two cases.
    Ravelli A; Caporali R; Bianchi E; Viola S; Solmi M; Montecucco C; Martini A
    Clin Exp Rheumatol; 1990; 8(1):95-8. PubMed ID: 2112074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
    Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
    Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia].
    Kienast J; Ostermann H; Stenzinger W; Kötter EM; van de Loo J
    Klin Wochenschr; 1989 Jul; 67(13):691-5. PubMed ID: 2502650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome.
    Asherson RA; Hughes GR
    J Rheumatol; 1989 Mar; 16(3):378-80. PubMed ID: 2498514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibodies in patients with systemic lupus erythematosus.
    Sturfelt G; Nived O; Norberg R; Thorstensson R; Krook K
    Arthritis Rheum; 1987 Apr; 30(4):382-8. PubMed ID: 3107577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
    Cervera R; Font J; López-Soto A; Casals F; Pallarés L; Bové A; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1990 Feb; 49(2):109-13. PubMed ID: 2107799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
    Zhou DC; Dong Y; Pan JQ
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
    Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
    Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for thrombosis in lupus patients.
    Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
    Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
    Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss.
    Creagh MD; Malia RG; Cooper SM; Smith AR; Duncan SL; Greaves M
    J Clin Pathol; 1991 Jan; 44(1):45-7. PubMed ID: 1900070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.